Steady-state Pharmacokinetics of Atazanavir/Cobicistat and Darunavir/Cobicistat Once Daily Over 72 Hours in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 26 Oct 2016
At a glance
- Drugs Atazanavir/cobicistat (Primary) ; Cobicistat/darunavir
- Indications HIV infections
- Focus Pharmacokinetics
- 21 Mar 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 09 Mar 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 04 Jan 2016 According to ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.